Profil
Ms. Sharon Barr is an EVP-BioPharmaceuticals Research & Development at AstraZeneca PLC and a Senior VP, Head-Research & Product Development at Alexion Pharmaceuticals, Inc.
Postes actifs de Sharon Barr
| Sociétés | Poste | Début |
|---|---|---|
| ASTRAZENECA PLC | Directeur Technique/Scientifique/R&D | 01/08/2023 |
| ALEXION PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
